Daily Briefing

What Changed

Today’s adoption of AI in safety-critical workflows demands clear governance to preserve accountability as regulatory expectations evolve [1].

Clinical Practice | A CNN-based AI system achieved 95.9% accuracy in detecting H. pylori infection in atrophic gastritis. A retrospective multicenter study of 22,986 patients and 464,480 endoscopic images from four centers showed the model outperformed senior endoscopists, whose accuracy fell to 69.9% in atrophic gastritis while the model maintained 95.9% accuracy. [2]

Operations & Workflow | R1's acquisition of Humata Health integrates AI-powered prior authorization technology into its revenue cycle platform to automate claims. R1 has agreed to acquire Humata Health, a company specializing in artificial intelligence-powered prior authorizations, to embed the technology within its revenue cycle platform for healthcare providers' claims processing automation. [3]

Clinical Practice | An AI-based prediction model developed using clinical and laboratory parameters improved antimicrobial resistance prediction in a prospective observational study. At Lady Reading Hospital, the model used clinical and lab data to forecast resistance, integrating rapid diagnostic testing and genotypic profiling in a resource‑limited setting with 410 adult patients suspected of bacterial infection. [4]

Industry & Products | Pharmacovigilance teams using AI for adverse event detection must implement governance frameworks with human-in-the-loop oversight. As adoption accelerates, organizations must ensure AI strengthens accountability, requiring clear governance frameworks to support automated processes and emphasize continual human‑in‑the‑loop oversight amid evolving global regulatory standards. [1]